#USA #San Francisco #Mira #Ultra4 #Hormone Testing

Mira's Ultra4 Hormone Monitor: A CES 2026 Honoree

Mira, a pioneer in the field of hormone health, has made headlines recently as its revolutionary Ultra4™ Hormone Monitor garnered recognition at the CES Innovation Awards® 2026 in the Digital Health category. This groundbreaking device is set to reshape the landscape of home-based health monitoring, making it possible to conduct lab-quality hormone testing in the comfort of one's home.

The Vision Behind Ultra4

At its core, the Ultra4 Monitor is designed to empower individuals by providing detailed insights into their hormonal health. Unlike traditional methods that require multiple visits to the lab, this monitor utilizes advanced fluorescent immunoassay technology to evaluate four crucial hormones all at once. These hormones include Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), Estrone-3-Glucuronide (E3G), and Pregnanediol Glucuronide (PdG). This capability allows users to receive comprehensive hormonal data through a simple 16-minute testing process.

Since its soft launch in August, the Ultra4 has demonstrated impressive demand, with tens of thousands of tests conducted already. Feedback from early users indicates that a significant 91% felt they gained a deeper understanding of their health issues, including symptoms such as fatigue, mood fluctuations, and irregular menstrual cycles.

A Wealth of Hormonal Data

Mira’s Hormone Intelligence™ Platform serves as the foundation for the Ultra4 Hormone Monitor. This sophisticated platform is based on nearly a decade's worth of real-world hormonal data, encompassing over 30 million data points. Initially focused on fertility, Mira has expanded its scope to illustrate how hormonal fluctuations influence various aspects of health, including energy levels, mood stability, metabolic rates, and age-related changes.

Mira's ambitious goal is to construct a fully integrated at-home health lab capable of evaluating multiple biomarkers comprehensively – beyond just hormones. Plans are in motion to create a system that synthesizes hormonal, metabolic, and biological information across different mediums such as urine, blood, and saliva.

Addressing Women's Health

The importance of this innovation cannot be overstated, especially in the context of women's health. Despite statistical evidence indicating that women generally live longer than men, they often spend a significant portion of their lives in poor health. Chronic conditions, frequently influenced by hormonal and metabolic imbalances, are not only prevalent but poorly understood.

Sylvia Kang, Mira’s CEO and co-founder, emphasizes the necessity of focusing on hormonal health, explaining, "We've spent nearly a decade collecting real-world hormonal data – now totaling more than 30 million data points. That data shows hormones influence far more than fertility. They sit at the center of how we feel, function, and age, which is why Ultra4 is just the beginning of a much broader vision for proactive, personalized health."

A Sneak Peek at CES 2026

At CES 2026, attendees will have the opportunity to explore Mira's Ultra4 and witness its transition into a comprehensive home lab setup aimed at promoting longevity and managing chronic health conditions. Those interested in learning more are encouraged to visit Mira at Booth #54298, where they can meet the team, including Kang herself.

Mira, founded in 2015 and based in San Francisco, is setting a new benchmark in the realm of hormonal health by blending advanced technology with the day-to-day health needs of individuals. As the company continues to roll out innovative health solutions, it solidifies its position as a leader in understanding female biology across all life stages, from menstruation to menopause and beyond.

For further information on the product and to stay updated on the latest developments, visit miracare.com.